RespireRx Pharmaceuticals Inc (fka RSPI)

[haysaw]

I think if they have to spend this much time fine-tuning the data on a tiny little study that took nearly two years (and at the rate of 1 enrollee per month, mind you), on the contrary, it looks weak and pathetic. But that is just par for the course when summing up this perpetual disappointment.